Thank you LifeArc and @camrare for the opportunity to collaborate with scientists, create a piece of art and show it at #latss2024 the first LifeArc Translational Science Summit in London. What a great day! I got to show my piece about lysosomal storage disorders
#sciart

Looking forward to an exciting day at the LifeArc Transitional Sciences Summit #LATSS2024

Advice for startups seeking investors- Franken: Europe has matured - you need a better pitch and willingness to be coached Dochez: do your homework, don’t be shy, learn from a “no” Charles - readiness to work early with scientific founders to build something together #LATSS2024

What a fantastic day at the LifeArc Translational Science Summit! Great to hear from leading #scientists , #investors & #innovators and build new connections in this exciting field! Thank you @LifeArc1 🙏
#LATSS2024 #translationalscience #lifescience #biotech #messengersinscience

Yosemite Neil White SROne Eliot Charles Droia Ventures Luc Dochez Gilde Healthcare Arthur Franken discuss financing strategies for life sciences #LATSS2024 LifeArc

Now entering the CEO war room with LifeArc Ventures Imran Hamid Abingworth Natalie Mount Closed Loop Medicine Hakim Yadi & RQ Bio’s Mike Westby LATSS2024 LifeArc

BioIndustry Association (BIA) Bates - UK has great competitive advantages in understanding biology, AI, connectivity - BIA membership changing to reflect AI and machine learning-biotech becoming techbio #LATSS2024

The afternoon #LATSS2024 Biotech Ventures stream begins with a focus on accelerators with LifeArc Jason Slingsby Babraham Research Campus Kathryn Chapman Francis Crick Barbara Domayne-Hayman & Start Codon Jason Mellad.

And the relentless pace continues #LATSS2024 next up nextgen university spinoffs with our own Chris Baker Cambridge Innovation Capital Anne Horgan Eos Deal Advisory Anne Muir Oxford Science Enterprises Katya Smirnyagina AlbionVC Simon Goldman

Excellent morning LifeArc translational science summit covering investment, clinical trials and small molecule design so far. So many ingredients to a thriving #biotech sector #LATSS2024

A powerful and moving session on the rare condition epidermolysis bullosa with DEBRA UK vice-president, Graeme Souness, sharing why he is working so hard to raise awareness, and from Lucy on the reality of living with the condition. #LATSS2024

Our CEO Susan Hill will be presenting at the LifeArc Translational Science Summit in London. She will review our lead program M300, which harnesses breakthroughs in tertiary lymphoid structure biology and is rapidly advancing towards the clinic. #LATSS2024 translationalsciencesummit.org

Packed room to hear Stephane Maikovsky, interim CEO at @LifeArc, get #LATSS2024 underway highlighting our legacy in accelerating promising science into new tests and treatments for patients, and welcoming new CEO Sam Barrell, who will join us in October.

Andy Dakin won the first artist's prize for Lucy's Wish which illustrates the visible difference and difficulties encountered through the eyes of a young girl with severe ichthyosis. Looking forward to Cambridge Rare Disease Network (CamRARE) in Nov. #raredisease #LATSS2024 ISG UK LifeArc

Head of LifeArc Ventures, Clare Terlouw, and kate bingham discuss how we can harness the UK’s world leading expertise and enhance collaborative partnerships to really make a difference for patients. #LATSS2024

Delighted to be at #LATSS2024 @Lifearc with artist Andy Dakin and Dr Elena Giusto to showcase our Translational art collaboration showing the difficulties of life with severe ichthyosis. ISG UK Thanks to Dr Carleen Walsh and family. #rareskindisease #dermtwitter

In our seats for opening of #LATSS2024 . Come and see us in a break upstairs refreshment area to find out more about the #TARnetwork and our new report.

Great to be working alongside Lucy Allen Cystic Fibrosis Trust and LifeArc at #LATSS2024 to promote cross sector collaboration and partnership. Very inspirational.

Happening today! Follow along on the hashtag #LATSS2024

Looking forward to this session at #LATSS2024 . Unlocking rare disease cures: navigating commercial challenges. How can we develop therapies and get them to the patient community?
#CMTASTAR #CMTresearch